JScreen Announces Screening for National Cancer Prevention Month
The Emory-based public health initiative recently added CancerGEN, an at-home genetic saliva test that screens for genetic risks for many types of cancers.
JScreen, a national nonprofit public health initiative dedicated to preventing genetic diseases and cancers common in the Jewish and other populations, recently added CancerGEN, an easy, at-home genetic saliva test that screens for genetic risks for many types of cancer.
Headquartered in Atlanta’s Emory University School of Medicine, JScreen provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services. JScreen believes the combination of education, access to premier genetic screening technologies and personalized, confidential support are the keys to preventing devastating diseases.
During the pandemic, Americans learned more and more about the importance of healthcare, with many of us taking more preventative measures against disease.
With the majority of cancer awareness months occurring in the fall — such as Breast Cancer in October and Prostate and Ovarian in September — JScreen emphasizes the importance of maintaining the same level of awareness year-round. The more people are screened, the more lives are saved. For more information, visit Jscreen.org.